ADCs present compelling opportunity to deliver crucial drugs, particularly for oncology medications
Indian pharma adopts green initiatives with eco-friendly manufacturing processes to save environment
Indian CDMOs expand capacities with Syngene taking the lead
Biopharma manufacturing turbulence boosts inquiries for India-based providers
Navigating the Pharma Landscape
AI and ML is changing the game of drug discovery
Formula for Success
Syngene: Weak funding environment leads to a soft patch
Healthcare demand drivers remain intact: Syngene MD
The nitty gritty of biotherapeutics production
